TITLE

ABC transporters and the Alzheimer's disease enigma

AUTHOR(S)
Wolf, Andrea; Bauer, Björn; Hartz, Anika M. S.; Vogelgesang, Silke; Jedlitschky, Gabriele
PUB. DATE
June 2012
SOURCE
Frontiers in Psychiatry;Jun2012, Vol. 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88074231

 

Related Articles

  • Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Herz, Joachim; Beffert, Uwe; Herz, J; Beffert, U // Nature Reviews Neuroscience;Oct2000, Vol. 1 Issue 1, p51 

    Alzheimer's disease is a debilitating neurodegenerative disorder that afflicts an increasing part of our ageing population. An isoform of apolipoprotein E, a protein that mediates the transport of lipids and cholesterol in the circulatory system, predisposes carriers of this allele to the common...

  • Clinico-Pathologic Function of Cerebral ABC Transporters - Implications for the Pathogenesis of Alzheimer's Disease. Pahnke, Jens; Wolkenhauer, Olaf; Krohn, Markus; Walker, Lary C. // Current Alzheimer Research;Oct2008, Vol. 5 Issue 4, p396 

    In recent years it has become evident that ABC transporters fulfill important barrier functions in normal organs and during disease processes. Most importantly, resistance to drugs in cancer cells led to intense oncological and pharmacological investigations in which researchers were able to...

  • Targeting CNS Transporters for Treatment of Neurodegenerative Diseases. Jedlitschky, Gabriele; Grube, Markus; Mosyagin, Igor; Kroemer, Heyo K.; Vogelgesang, Silke // Current Pharmaceutical Design;Mar2014, Vol. 20 Issue 10, p1523 

    Molecular transporters that are expressed in brain, especially at the blood-brain barrier (BBB), are increasingly recognized as possible therapeutic targets in the treatment of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Some ATP-binding cassette (ABC)...

  • ABC Transporters B1, C1 and G2 Differentially Regulate Neuroregeneration in Mice. Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Fr�hlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Br�ning, Thomas; Heinze, Hans-Jochen; Pahnke, Jens // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: ATP-binding cassette (ABC) transporters are essential regulators of organismic homeostasis, and are particularly important in protecting the body from potentially harmful exogenous substances. Recently, an increasing number of in vitro observations have indicated a functional role of...

  • ABC Transporters B1, C1 and G2 Differentially Regulate Neuroregeneration in Mice. Schumacher, Toni; Krohn, Markus; Hofrichter, Jacqueline; Lange, Cathleen; Stenzel, Jan; Steffen, Johannes; Dunkelmann, Tina; Paarmann, Kristin; Fröhlich, Christina; Uecker, Annekathrin; Plath, Anne-Sophie; Sommer, Alexandra; Brüning, Thomas; Heinze, Hans-Jochen; Pahnke, Jens // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: ATP-binding cassette (ABC) transporters are essential regulators of organismic homeostasis, and are particularly important in protecting the body from potentially harmful exogenous substances. Recently, an increasing number of in vitro observations have indicated a functional role of...

  • PET and SPECT Radiotracers to Assess Function and Expression of ABC Transporters In Vivo. Mairinger, Severin; Erker, Thomas; Müller, Markus; Langer, Oliver // Current Drug Metabolism;Oct2011, Vol. 12 Issue 8, p774 

    Adenosine triphosphate-binding cassette (ABC) transporters, such as P-glycoprotein (Pgp, ABCB1), breast cancer resistance protein (BCRP, ABCG2) and multidrug resistance-associated proteins (MRPs) are expressed in high concentrations at various physiological barriers (e.g. blood-brain barrier,...

  • Accumulation of murine amyloid-? mimics early Alzheimer's disease. Krohn, Markus; Bracke, Alexander; Avchalumov, Yosef; Schumacher, Toni; Hofrichter, Jacqueline; Paarmann, Kristin; Fröhlich, Christina; Lange, Cathleen; Brüning, Thomas; von Bohlen und Halbach, Oliver; Pahnke, Jens // Brain: A Journal of Neurology;Aug2015, Vol. 138 Issue 8, p2370 

    Amyloidosis mouse models of Alzheimer's disease are generally established by transgenic approaches leading to an overexpression of mutated human genes that are known to be involved in the generation of amyloid-? in Alzheimer's families. Although these models made substantial contributions to the...

  • The Role of the ATP-Binding Cassette Transporter P-Glycoprotein in the Transport of β-Amyloid Across the Blood-Brain Barrier. Vogelgesang, Silke; Jedlitschky, Gabriele; Brenn, Anja; Walker, Lary C. // Current Pharmaceutical Design;9/1/2011, Vol. 17 Issue 26, p2778 

    The blood-brain barrier (BBB) protects the brain against endogenous and exogenous compounds and plays an important part in the maintenance of the microenvironment of the brain. In particular, the importance of brain-to-blood transport of brain-derived metabolites across the BBB has gained...

  • Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease. Bartels, A. L. // Current Pharmaceutical Design;9/1/2011, Vol. 17 Issue 26, p2771 

    Protection of the brain is strengthened by active transport and ABC transporters. P-glycoprotein (P-gp) at the blood-brain barrier (BBB) functions as an active efflux pump by extruding a substrate from the brain, which is important for maintaining loco-regional homeostasis in the brain and...

  • Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice. Krohn, Markus; Lange, Cathleen; Hofrichter, Jacqueline; Scheffler, Katja; Stenzel, Jan; Steffen, Johannes; Schumacher, Toni; Brüning, Thomas; Plath, Anne-Sophie; Alfen, Franziska; Schmidt, Anke; Winter, Felix; Rateitschak, Katja; Wree, Andreas; Gsponer, Jörg; Walker, Lary C.; Pahnke, Jens; Brüning, Thomas; Gsponer, Jörg // Journal of Clinical Investigation;Oct2011, Vol. 121 Issue 10, p3924 

    In Alzheimer disease (AD), the intracerebral accumulation of amyloid-β (Aβ) peptides is a critical yet poorly understood process. Aβ clearance via the blood-brain barrier is reduced by approximately 30% in AD patients, but the underlying mechanisms remain elusive. ABC transporters have...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics